At 36, he chairs NG Biotech, which has developed a rapid serological test to detect Covid-19. He faces multiple requests and doubles the size of his business, given the orders, including that expected this Monday from the Public Assistance-Hospitals of Paris.Pharmacy -
By Stanislas du Guerny
Posted on May 18, 2020 at 7:00 a.m.
To be wise ? Milovan Stankov Pugès knew how to keep it. At 36, the young CEO has demonstrated this in recent weeks. The name of his company, NG Biotech, circulated on news channels and was enthroned in the front page of the press: in April, the Ministry of the Armed Forces announced that it would support its serological tests with 1 million euros Covid-19 ultra-fast detection system. For its part, the Public Assistance-Hospitals of Paris would be on the verge of announcing this Monday a new purchase of these tests, supposed to reveal in about fifteen minutes, from a drop of blood, if a person is or has been in contact with the virus.
